This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: BAC BIIB GS JPM MDT

Stocks in this article: BAC BIIB GS JPM MDT


Align Technology (ALGN) was upgraded at Morgan Stanley from underweight to equal weight. Company should see better consumer trends and easing competition, Morgan Stanley said.

Allot Communications (ALLT) was downgraded at Oppenheimer to perform from outperform. Checks point to slowdown, Oppenheimer said.

Bank of America (BAC) was upgraded at JMP Securities from underperform to market perform. Estimates were also boosted, given higher expected industry sales growth, JMP said.

CR Bard (BCR) was downgraded at Morgan Stanley from equal weight to underweight. $91 price target. Company has a premium valuation, but is growing slower than its peers, Morgan Stanley said.

Biogen Idec (BIIB) was downgraded at Piper Jaffray from overweight to neutral. Valuation call, based on a $168 price target, Piper Jaffray said.

Citigroup (C) was upgraded at JMP Securities from underperform to market perform. Company is leveraged to continued economic growth, JMP said.

Citigroup was upgraded at Sterne Agee to buy from neutral. $50 price target. New CEO is a positive and the company remains the cheapest stock in the sector, Sterne Agee said.

Clear Channel Outdoor Holdings (CCO) was downgraded at Wedbush to underperform from neutral. $6 price target. Weak 4Q checks, Wedbush said.

DR Horton (DHI) was upgraded at Stifel Nicolaus from sell to hold. Valuation call, as the sector has sustainable growth tailwinds, Stifel Nicolaus said.

Synageva (GEVA) was downgraded at Piper Jaffray from overweight to neutral. $57 price target. Company lacks near-term catalysts, Piper Jaffray said.

Goldman Sachs (GS) was upgraded at JMP Securities from underperform to market perform. Earnings should improve in the coming quarters, JMP Securities said.

Health Net (HNT) was upgraded at Deutsche Bank from sell to hold. Valuation call, Deutsche Bank said.

JPMorgan Chase was upgraded at JMP Securities from underperform to market perform. Industry should see higher sales in key areas, JMP said.

Kronos Worldwide (KRO) was downgraded at Oppenheimer to perform from outperform. Comps will remain negative in the first half, Oppenheimer said.

Medtronic (MDT) was upgraded at Mizuho from neutral to buy. $49 price target. Spine business should grow through new products and insurance expansion, Mizuho said.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs